Skye Bioscience Inc (SKYE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -41,483 | -28,728 | -11,103 | -26,567 | -16,821 |
| Depreciation Amortization | 543 | 364 | 177 | 898 | 722 |
| Accounts payable and accrued liabilities | 2,187 | 2,585 | 1,216 | -587 | -376 |
| Other Working Capital | 1,675 | 4,286 | -461 | -2,629 | -1,759 |
| Other Operating Activity | 3,782 | 1,561 | 986 | 3,647 | 1,169 |
| Operating Cash Flow | $-33,296 | $-19,932 | $-9,186 | $-25,238 | $-17,064 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -16,871 | -24,747 | -12,803 | N/A | N/A |
| PPE Investments | 175 | 83 | -6 | -246 | -336 |
| Investing Cash Flow | $-16,697 | $-24,664 | $-12,809 | $-246 | $-336 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 18 | 18 | 0 | 6 | 83,557 |
| Other Financing Activity | 0 | 0 | 0 | 83,557 | 0 |
| Financing Cash Flow | $18 | $18 | $0 | $83,562 | $83,557 |
| Beginning Cash Position | 68,416 | 68,416 | 68,416 | 10,337 | 10,337 |
| End Cash Position | 18,441 | 23,838 | 46,421 | 68,416 | 76,493 |
| Net Cash Flow | $-49,975 | $-44,578 | $-21,994 | $58,079 | $66,156 |
| Free Cash Flow | |||||
| Operating Cash Flow | -33,296 | -19,932 | -9,186 | -25,238 | -17,064 |
| Capital Expenditure | -6 | -6 | -6 | -1,604 | -1,554 |
| Free Cash Flow | -33,302 | -19,938 | -9,192 | -26,842 | -18,618 |